HomeRXK3 • FRA
add
Sellas Life Sciences Group Inc
Previous close
€1.03
Day range
€1.02 - €1.04
Year range
€0.45 - €1.77
Market cap
63.52M USD
Avg Volume
960.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.64M | -14.50% |
Net income | -9.57M | 13.80% |
Net profit margin | — | — |
Earnings per share | -0.21 | 55.32% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 18.42M | -22.96% |
Total assets | 24.43M | -16.05% |
Total liabilities | 14.75M | -7.44% |
Total equity | 9.68M | — |
Shares outstanding | 57.75M | — |
Price to book | 6.08 | — |
Return on assets | -157.33% | — |
Return on capital | -1,412.15% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -9.57M | 13.80% |
Cash from operations | -10.76M | 11.26% |
Cash from investing | — | — |
Cash from financing | 26.65M | 40.95% |
Net change in cash | 15.88M | 134.40% |
Free cash flow | -7.34M | 8.97% |
About
Founded
2006
Website
Employees
16